# Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Gastric Cancer

> **NCT01305993** · PHASE2 · UNKNOWN · sponsor: **SBPharmaceutical IND, Co., LTD** · enrollment: 26 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** SB injection

## Key facts

- **NCT ID:** NCT01305993
- **Lead sponsor:** SBPharmaceutical IND, Co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-05
- **Primary completion:** 2011-12
- **Final completion:** —
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2011-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01305993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01305993, "Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Gastric Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01305993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*